885266-93-3 Usage
Uses
Used in Organic Synthesis:
2,5-Bis-(difluoromethoxy)-bromobenzene is used as a key building block for the synthesis of various pharmaceuticals, agrochemicals, and materials. Its unique structure and reactivity contribute to the production of a wide range of complex organic compounds.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,5-Bis-(difluoromethoxy)-bromobenzene is used as an intermediate for the development of new drugs. Its specialized properties allow for the creation of molecules with specific therapeutic effects.
Used in Agrochemical Industry:
2,5-Bis-(difluoromethoxy)-bromobenzene is also utilized as a precursor in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Materials Science:
2,5-Bis-(difluoromethoxy)-bromobenzene may have potential applications in the development of new materials and technologies due to its specialized properties, such as in the creation of advanced polymers or other material systems.
Used in Research and Development:
2,5-Bis-(difluoromethoxy)-bromobenzene is used as a research chemical in the study of organic reactions and mechanisms, aiding scientists in understanding and optimizing various chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 885266-93-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,6 and 6 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 885266-93:
(8*8)+(7*8)+(6*5)+(5*2)+(4*6)+(3*6)+(2*9)+(1*3)=223
223 % 10 = 3
So 885266-93-3 is a valid CAS Registry Number.
885266-93-3Relevant academic research and scientific papers
TETRAZOLE-SUBSTITUTED PYRAZOLOPYRIMIDINE INHIBITORS OF JAK KINASES AND USES THEREOF
-
Page/Page column 101, (2021/01/22)
Compounds of formula (I) wherein R1, R2, R3, R4, R5 and R6 are as defined herein, and salts thereof, that are useful as JAK kinase inhibitors are described herein. Also provided are pharmac
PYRAZOLOPYRIMIDINE COMPOUNDS AS JAK INHIBITORS
-
Page/Page column 69, (2019/08/20)
Compounds and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
THERAPEUTIC COMPOUNDS AND COMPOSITIONS, AND METHODS OF USE THEREOF
-
Paragraph 0332-0333, (2018/12/04)
Compounds and salts thereof that are useful as JAK kinse inhibitors are described herein. Also provided are pharmaceutical compositions that include such a JAK inhibitor and a pharmaceutically acceptable carrier, adjuvant or vehicle, and methods of treating or lessening the severity of a disease or condition responsive to the inhibition of a Janus kinase activity in a patient.
